Chen, L., Liu, Y., Dong, L
Out of these trials, 92% noticed fewer wrinkles and improved skin
The source trail for this page is checked against Emerging pharmacotherapies for obesity: A systematic review (2025), Glucagon-like receptor agonists and next-generation incretin-based medications (2026), and Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), plus the creator's own wording
Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
Researchers also explore GLP-3 - GLP-3 is a GLP-1 receptor agonist for metabolic and weight-loss research.
None of these are sterile, and all will introduce contaminants that make injection dangerous